Adherence to antihyperglycemic treatment: a work in progress

Expert Opinion on Pharmacotherapy

Volumn 17, Issue 12, 2016, Pages 1579-1580

  Tziomalos, Konstantinos ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

adherence; antihyperglycemic treatment; compliance; human insulins; insulin analogs; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT;

DIABETIC PATIENT; EDITORIAL; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HOSPITAL COST; HUMAN; INSULIN TREATMENT; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 84976321013     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1080/14656566.2016.1202922     Document Type: Editorial

References (15)

1. P.Z.Zimmet, D.J.Magliano, W.H.Herman, et al. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2:56–64.
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853.
3. B.Zinman, C.Wanner, J.M.Lachin, et al. EMPA-REG OUTCOME investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–2128.
4. A.J.Farmer, L.R.Rodgers, M.Lonergan, et al. MASTERMIND Consortium. Adherence to oral glucose-lowering therapies and associations with 1-Year HbA1c: a retrospective cohort analysis in a large primary care database. Diabetes Care. 2016;39:258–263.
5. M.S.Kirkman, M.T.Rowan-Martin, R.Levin, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38:604–609.
6. B.J.Quilliam, A.B.Ozbay, B.E.Sill, et al. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes. Diabet Med. 2013;30:1305–1313.
7. T.Lokhandwala, N.Smith, C.Sternhufvud, et al. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs. J Med Econ. 2016;19:203–212.
8. E.Chong, H.Wang, K.M.King-Shier, et al. Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with type 2 diabetes mellitus: a population-based cohort study. Diabet Med. 2014;31:1586–1593.
9. M.Peyrot, A.H.Barnett, L.F.Meneghini, et al. Factors associated with injection omission/non-adherence in the global attitudes of patients and physicians in insulin therapy study. Diabetes Obes Metab. 2012;14:1081–1087.
10. D.G.Yavuz, S.Ozcan, O.Deyneli Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens. Patient Prefer Adherence. 2015;9:1225–1231.
11. Comparison of medication compliance in diabetes mellitus patients on human versus analogue insulins. Expert Opin Pharmacother. Forthcoming 2016.•• The first study that compared adherence to human insulin with analogue insulin.
12. K.Horvath, K.Jeitler, A.Berghold, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;2:CD005613.
13. S.Sapkota, J.A.Brien, J.Greenfield, et al. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes–impact on adherence. PLoS One. 2015;10:e0118296.• A recent and comprehensive meta-analysis of studies that evaluated interventions aiming at improving adherence to antidiabetic medications.
14. M.L.Parchman, J.E.Zeber, R.F.Palmer. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8:410–417.
15. L.E.Egede, M.Gebregziabher, C.E.Dismuke, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012;35:2533–2539.